Evaluation of Mitochondrial Function on Pyruvate Dehydrogenase Complex Deficient Patient-derived Cell Lines

Area of Science:

• Biochemistry
• Cell Biology
• Metabolic Disorders

Background:

• Pyruvate Dehydrogenase Complex (PDC) is crucial for aerobic energy metabolism, linking glycolysis to oxidative phosphorylation.
• PDC deficiency, often due to PDHA1 mutations, causes energy deficits in nervous and muscular tissues.
• Investigating therapeutic interventions for PDC deficiency is vital due to its debilitating effects.

Purpose of the Study:

• To evaluate the therapeutic potential of arginine and thiamine in improving mitochondrial function in patient-derived cells with PDC deficiency.
• To assess the impact of arginine and thiamine on the bioenergetic profile of cells with PDHA1 variants.

Main Methods:

• PDC-deficient cell lines with three different PDHA1 variants were cultured with and without arginine (4 mM) and thiamine (100 μM).
• Mitochondrial bioenergetics were analyzed using a Seahorse extracellular flux analyzer.
• Oxygen consumption rate and ATP-linked respiration were key parameters measured.

Main Results:

• PDC-deficient cells exhibited lower basal respiration compared to controls.
• Arginine and thiamine supplementation normalized or increased basal oxygen consumption in deficient cells.
• The treatment revealed inefficient oxidative phosphorylation and highlighted reliance on glycolysis for ATP production in these cell lines.

Conclusions:

• Arginine and thiamine, at therapeutic concentrations, enhance basal oxygen consumption rate in PDC-deficient cell lines.
• Supplementation improves ATP-linked respiration, indicating increased electron flow and oxidative phosphorylation.
• This suggests arginine and thiamine can bolster mitochondrial bioenergetics and cellular robustness in PDC deficiency.